Company Overview
AURINIA PHARMACEUTICALS INC.
AUPHRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
283M
2025 FY
Net Income
287M
2025 FY
Shares Outstanding
134M
2025 FY
EPS
2.14USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1600620
Exchange
Nasdaq
Location
CA